Some of the names on the move ahead of the open.» Read More
European stocks slid to close sharply lower as investors remained pessimistic on global economic growth prospects.
U.S. stock futures were under pressure this morning, after a big drop in Japanese stocks.
The rapid spread of the zika virus has spurred the hunt for a cure, but the financial incentive and likely length of time for a vaccine are unclear.
*Sanofi and Mannkind terminate deal for Afrezza. LONDON, Jan 5- French drugmaker Sanofi is to stop selling an inhalable insulin developed by Mannkind, following disappointing sales of the product since its launch in February 2015. Rights to Afrezza will revert to Mannkind from Sanofi in the next 90 to 180 days and Mannkind said it was reviewing strategic options...
European stocks closed flat on Thursday in a shortened trading day with thin volumes as the oil price remained choppy.
European markets accelerated gains on Wednesday to close sharply higher, as investors cheered the recovery in oil prices and mining stocks.
PARIS, Dec 23- French drugmaker Sanofi said on Wednesday it had submitted an application to the U.S. Food and Drug Administration for a single daily insulin injection to treat adults with type 2 diabetes. Sanofi said it had requested a six-month review of its new drug application by the FDA, rather than the standard 10 months. "A large unmet medical need still exists...
*Zoetis, Pfizer assets could attract Bayer in future. Possible targets for the German company could include veterinary drug firm Zoetis and Pfizer's consumer health business, the two sources said. Bayer, Zoetis and Pfizer declined to comment.
Dec 16- The U.S. Food and Drug Administration on Wednesday approved Eli Lilly& Co's diabetes drug Basaglar, a cheaper version of Sanofi AG's top-selling drug Lantus. In September Lilly entered a settlement agreement to resolve patent litigation with Sanofi over Basaglar, allowing Lilly and its partner, Boehringer Ingelheim, to launch Basaglar in the United...
Check out the companies making headlines after the bell Tuesday: Amgen, Advanced Auto Parts, Lumber Liquidators & more.
*M&A deals lift Faurecia and Sanofi. LONDON, Dec 15- European equities bounced back on Tuesday from sharp declines in the previous two sessions as energy stocks tracked higher crude oil prices and steel makers gained following a European Commission move on Chinese and Russian steel imports. BP, BG Group and Royal Dutch Shell rose 2.6 to 4.0 percent.
*M&A deals lift Faurecia and Sanofi. LONDON, Dec 15- European equities bounced back on Tuesday from sharp declines in the previous two sessions as energy stocks tracked higher crude oil prices and steel makers gained following a European Commission move on Chinese and Russian steel imports. BP, BG Group and Royal Dutch Shell rose 2 to 3.5 percent.
Some of the names on the move ahead of the open.
U.S. stock futures were sharply higher this morning, after Monday's strong gains on Wall Street.
*M&A deals lift Faurecia and Sanofi. The Paris market was helped by French pharmaceuticals group Sanofi, which climbed 4.1 percent after it said it would swap some assets with Boehringer Ingelheim. There was also an 8.5 percent surge in car parts company Faurecia after it agreed to sell a division to Plastic Omnium.
*Sanofi in talks to acquire Boehringer consumer health. *Boehringer to buy Sanofi's animal health arm Merial. PARIS/ LONDON, Dec 15- Sanofi and Boehringer Ingelheim are in exclusive talks over a $20 billion swap of the French pharmaceuticals company's animal health business for the family-owned German group's consumer health operation.
LONDON, Dec 15- European shares rose on Tuesday to bounce back from stinging losses in the previous session, as gains in major French companies propped up the region's equity markets. The Paris market was helped by French pharmaceuticals group Sanofi, which climbed 4 percent after it said it would swap some assets with Boehringer Ingelheim.
PARIS, Dec 9- Sanofi's dengue vaccine is to make its market debut in Mexico, the French drugmaker said on Wednesday, adding that it expects to have filed for market approval in some 20 countries by year-end. Sanofi Pasteur, the group's vaccines division, said Mexico had approved the preventive treatment, called Dengvaxia, for all four dengue virus serotypes, but...
LONDON, Dec 7- European shares rose on Monday to climb back up from three-week lows reached last week, although Electrolux slumped after its deal to buy General Electric's appliance business fell through. The broader European stock markets were supported by a rise in major healthcare stocks, with Novartis advancing on positive results for a...
*Local drugs intensify competition as China squeezes prices. SHANGHAI, Nov 29- China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and aging population. That has made China a sweet spot for Denmark's Novo Nordisk; the world's biggest...